Jinxin Fertility Group Past Earnings Performance
Past criteria checks 4/6
Jinxin Fertility Group's earnings have been declining at an average annual rate of -4.1%, while the Healthcare industry saw earnings declining at 0.9% annually. Revenues have been growing at an average rate of 17.8% per year. Jinxin Fertility Group's return on equity is 3.4%, and it has net margins of 12.4%.
Key information
-4.1%
Earnings growth rate
-13.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 17.8% |
| Return on equity | 3.4% |
| Net Margin | 12.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Jinxin Fertility Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,789 | 345 | 673 | 22 |
| 30 Sep 23 | 2,675 | 250 | 659 | 23 |
| 30 Jun 23 | 2,560 | 155 | 644 | 23 |
| 31 Mar 23 | 2,462 | 138 | 627 | 20 |
| 31 Dec 22 | 2,364 | 121 | 610 | 17 |
| 30 Sep 22 | 2,241 | 248 | 535 | 14 |
| 30 Jun 22 | 2,118 | 374 | 460 | 10 |
| 31 Mar 22 | 1,978 | 357 | 425 | 11 |
| 31 Dec 21 | 1,839 | 340 | 389 | 11 |
| 30 Sep 21 | 1,756 | 316 | 382 | 11 |
| 30 Jun 21 | 1,674 | 291 | 376 | 12 |
| 31 Mar 21 | 1,550 | 271 | 346 | 12 |
| 31 Dec 20 | 1,426 | 252 | 317 | 11 |
| 30 Sep 20 | 1,448 | 304 | 301 | 12 |
| 30 Jun 20 | 1,469 | 356 | 286 | 12 |
| 31 Mar 20 | 1,559 | 383 | 280 | 13 |
| 31 Dec 19 | 1,648 | 410 | 274 | 13 |
| 30 Sep 19 | 1,475 | 339 | 220 | 13 |
| 30 Jun 19 | 1,301 | 269 | 166 | 12 |
| 31 Mar 19 | 1,112 | 218 | 135 | 12 |
| 31 Dec 18 | 922 | 167 | 103 | 12 |
| 31 Dec 17 | 663 | 99 | 60 | 10 |
| 31 Dec 16 | 346 | 88 | 26 | 0 |
Quality Earnings: 3NX has high quality earnings.
Growing Profit Margin: 3NX's current net profit margins (12.4%) are higher than last year (5.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3NX's earnings have declined by 4.1% per year over the past 5 years.
Accelerating Growth: 3NX's earnings growth over the past year (184.6%) exceeds its 5-year average (-4.1% per year).
Earnings vs Industry: 3NX earnings growth over the past year (184.6%) exceeded the Healthcare industry -2.2%.
Return on Equity
High ROE: 3NX's Return on Equity (3.4%) is considered low.